News

Even in mild cases, symptoms of COVID-19 can linger for at least 8 months, according to new research.

CDC report highlights disparities among “racial, ethnic, gender, and sexual” minorities.

Treatment with rifampin shows it can increase the chances for recurrent Clostridium difficile (C diff) infection according to investigators in Mexico.

The Biden Administration plans to donate the AstraZeneca vaccines globally upon clearance of safety reviews.

Thailand steps up travel restrictions among a rapidly spreading third wave of the disease.

There have been sporadic cases Hemophagocytic Lymphohistiocytosis, associated with Cytomegalovirus Infection infection, suggesting that CMV may cause clinically significant disease beyond mononucleosis in immunocompetent individuals.

The discovery of C diff’s ability to harness heme to shield itself from the body’s immune responses hopefully brings a new dimension to the fight against the damaging pathogen.

Nursing home residents who had recovered from COVID-19 showed robust antibody levels against the SARS-CoV-2 spike protein after 1 dose of messenger RNA (mRNA) vaccine, a study in France showed.

CDI prevalence among those hospitalized with a COVID-19 infection was not found to be increased despite more use of antibiotics.

The 6th major component of the 1-year old ACTIV public-private initiative of the NIH will test candidate drugs to repurpose for COVID-19.

Providing support to communities of color could encourage participation and improve uptake.

Short-course antibiotics are preferable for certain common bacterial infections, including acute bronchitis, pneumonia, urinary tract infection and cellulitis, the American College of Physicians said in a report issuing practice advice.

Experts discuss the bacteria’s transmission in the community setting, how to reduce disease and economic burdens, and ways to improve quality of life for patients.

While the addition of outside air into a building showed a clear benefit, too much air exchange can have a negative impact.

New analysis of registry data suggest pregnant persons are not facing particularly worse pregnancy nor neonatal outcomes after mRNA vaccination.

Two cases in the United States showed reinfection after administration of the m-RNA vaccines may complicate protection against new variants, but lend support to a potential need for a booster.

The Johnson & Johnson shot showed an efficacy of 66.9% and 66.1% on the 2 primary endpoints, with a higher efficacy against severe-critical disease.

While no evidence of any viral RNA was detected in patients brain cells, investigators found a significant amount of neurological damage.

A study of more than 400 hospitals offers takeaways for creating antibiotic stewardship programs in hospitals around the country.

Escalating usage and more drug choices are putting more people at risk.

High levels of anxiety among immunocompromised children and their guardians highlights the need to clearly define COVID-19 risk.

Federal regulators authored a 12 page report citing several examples of misconduct within the plant, including improperly trained employees.

Simple daily measures could help to lower the risk of severe disease and transmission, including using mouthwash.

Severe blood clots reported with 2 COVID-19 vaccines are rare, but possible heightening of vaccine hesitancy would lower floodgates to pandemic waves

A marker that triggers T cells to fight an infection in the gut was found in small numbers in those with a SARS-CoV-2 infection.

The SAA biomarker could allow physicians the opportunity to better care for and manage a patient’s course of disease.

The committee stressed that the events are exceedingly rare, and that the vaccine's benefits outweigh the potential risks.

The Centers for Disease Control and Prevention (CDC) announced that doing so offers very little in terms of protecting against transmission of the airborne virus.